Laboratory detection of 'aspirin resistance': what test should we use (if any)?

Abstract

Aspirin is widely used to decrease the risk of occlusive arterial events in patients at risk. It irreversibly inhibits the cyclooxygenase-1 (COX-1)-dependent synthesis of thromboxane A₂ (TxA₂), which is essential for the full aggregation response of platelets.